Abstract Body

Background

Broadly neutralizing antibodies (bnAbs) targeting the V2-apex of the HIV-1 envelope glycoprotein (Env) are among the most potent, with potential utility for prevention and therapy. However, V2 bnAbs have low activity against Envs lacking K/R169, as in 88% of subtype B and 26% of recent subtype C Envs (Mkhize et al, 2023). Furthermore, subtype B infections rarely trigger prototypic V2 bnAbs (Rusert et al, 2016), suggesting K/R169 may be a key regulator of V2 bnAb induction. Increasing the coverage of resistance mutations at K169 is crucial to leverage the potential of V2 bnAbs.

Methods

The bnAb SHCS-0170 was isolated from the XbnAb cohort, comprising 304 bnAb inducers from the Swiss HIV Cohort Study (SHCS) (Pasin et al, biorxiv 2024). Neutralization activities of V2 bnAbs (N=28) and XbnAb plasmas (N=304) were assessed against a multi-clade Env pseudovirus panel (N=41). Epitope mapping included binding antibody multiplex assays with 16 Env targets, Env mutant neutralization and Cryo-EM structure analysis. 

Results

Isolated from a subtype B donor with multispecific bnAb activity, SHCS-0170 had 80% breadth at a geometric mean IC50 0.43 µg/mL. Intriguingly, given the rarity of V2 bnAbs in subtype B, SHCS-0170 neutralization correlated strongly with V2 bnAb PGT145 (Spearman’s rho=0.72). SHCS-0170 neutralized 86% of subtype B viruses, outperforming other V2 bnAbs. Epitope mapping showed N160-dependent neutralization and binding but, consistent with its high breadth, SHCS-0170 tolerated variation at Env positions 164, 166, 167, 169 and 171. A 2.9Å structure in complex with BG505.SOSIP trimer confirmed that SHCS-0170 did not interact with K169. The long beta-hairpin CDRH3 reached an extreme trimer penetration depth of 24.6Å inserting a sulfated tyrosine residue between protomers that interacts with Env residues K121 (97% conserved across subtypes) and Q315 (Q315R/K in 84% of subtype B). Thus, SHCS-0170 reached K169-independence by targeting positive charges at positions 121 and 315. Clustering of Spearman correlations between neutralization fingerprints of XbnAb plasmas and V2 bnAbs suggested that K169-independent classes may be more commonly elicited by subtype B Envs than other prototype V2 bnAbs (mixed effects model p<0.001). 

Conclusions

SHCS-0170 represents a novel K169-independent V2 bnAb that may be prevalent in subtype B infection. The complementarity of its epitope, relative to other V2 bnAbs, provides opportunities for combination bnAb therapy and vaccines across subtypes.